Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytek BioSciences

3.65
-0.0200-0.54%
Post-market: 3.650.00000.00%16:35 EDT
Volume:424.93K
Turnover:1.55M
Market Cap:467.56M
PE:-73.00
High:3.68
Open:3.65
Low:3.47
Close:3.67
Loading ...
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 02, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals